Latest Breaking News On - Josh schimmer - Page 1 : comparemela.com

CG follows big IPO with new results for bladder cancer drug

BioPharma

Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent

2 Top Growth Stocks to Buy With $1,000 Right Now

Even a modest starting investment in the right stocks could pay off in the years ahead.

12 Most Promising Stocks to Buy According to Hedge Funds

In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.

Cabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T Drugs

By Josh Beckerman Cabaletta Bio shares were down 32% to $12.72 after the U.S. Food and Drug Administration said it is looking into reports of T-cell malignancies in patients who received.